Tom Coaker
AssociateCapital Markets
Global HeadquartersGB
Tom joined Knight Frank in 2020, having previously worked in the Capital Market teams at Cushman & Wakefield & DTZ. Tom started in the Portfolio and Special Situations Team before transferring into the National Office, Life Science, and Innovation team in 2024. He focuses on acquisition and disposal instructions across the UK and has been involved in a number of high profile complex transactions . Key clients include Brookfield, Columbia Threadneedle, Orchard Street and Royal London.